BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 2012
View Archived Issues
Marketed anticancer drug shows potential to treat Alzheimer's disease
Read More
Trimel provides update on intranasal gel for female anorgasmia
Read More
NIH to fund development of next-generation biodefense vaccines
Read More
Small-molecule interferon receptor agonist holds promise to treat hepatitis C
Read More
Analyte-responsive microscale pumps designed at Penn State
Read More
Large-scale European phase III study to assess nilvadipine
Read More
Summit discloses phase I study plans for candidate DMD treatment
Read More
FDA approves second-generation prostate cancer test
Read More
Novel P13K inhibitors patented by Roche
Read More
Recruitment begins in phase II ISIS-APOCIIIRx trial
Read More
EpiTherapeutics divulges new GASC-1 inhibitors
Read More
Phase II ofatumumab/GSK-2110183 combination study enters recruitment phase
Read More
Novel metabotropic glutamate mGlu4 receptor modulators identified
Read More
Shire reports active fourth quarter 2011
Read More
RedHill Biopharma begins advanced-stage clinical trial of RHB-102
Read More
Bionor provides update on development of HIV vaccine
Read More
Glenveigh Medical digoxin antidote gets orphan drug designation
Read More
FDA accepts NDA for tafamidis
Read More
Edgemont Pharmaceuticals obtains license to market CPI-300 in U.S.
Read More
New serotonin receptor antagonists patented in Japan
Read More
Ono Pharmaceutical updates progress of third quarter of fiscal 2011
Read More
Bristol-Myers Squibb develops new candidate cancer therapeutics
Read More
Multicenter study validates prognostic tool for use in patients comatose after cardiac arrest
Read More
Renal function marker is associated with severity of cerebral small vessel disease
Read More
Pfizer presents novel candidate pain treatments
Read More
FDA approves new gel for male hypogonadism
Read More